Supriya Lifescience Q2 Results
- BSE: 543434
- NSE: SUPRIYA
- ISIN: INE07RO01027
- Sector: Biotechnology & Drugs
BSE
904.55
-11.10 (-1.21%)
-11.10 (-1.21%)Volume3.39 K
Updated: Wed 9 Sep, 2026 | 10:07:12
NSE
909-6.65 (-0.73%)
-6.65 (-0.73%)Volume48.02 K
Updated: Wed 9 Sep, 2026 | 09:53:05
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Supriya Lifescience Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 133.83 | 151.23 | 34.06% | 106.13 | 26.10% |
| Depreciation/ Amortization | 6.64 | 8.94 | 2.91% | 4.74 | 39.95% |
| Operating Income | 66.01 | 38.52 | 45.87% | 59.97 | 10.06% |
| Net Income | 50.43 | 24.04 | 44.95% | 46.15 | 9.27% |
| Other Operating Expenses Total | 46.98 | 57.41 | 20.72% | 35.73 | 31.49% |
| Net Income Before Taxes | 68.32 | 40.79 | 44.09% | 62.06 | 10.08% |
| Total Revenue | 199.83 | 189.75 | 37.75% | 166.10 | 20.31% |
| Selling/ General/ Admin Expenses Total | 24.48 | 28.49 | 7.90% | 19.69 | 24.36% |
| Diluted Normalized EPS | 6.27 | 2.99 | 45.14% | 5.71 | 9.81% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.